Device
Aquablation Therapy
Aquablation Therapy is a medical device with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
active_not_recruiting267%
not_yet_recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
WATER IV PCa (AS Sub-study)
NCT07650448
active_not_recruitingnot_applicable
WATER IV Prostate Cancer
NCT06651632
active_not_recruitingnot_applicable
WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia
NCT04801381
Clinical Trials (3)
Showing 3 of 3 trials
NCT07650448Not Applicable
WATER IV PCa (AS Sub-study)
NCT06651632Not Applicable
WATER IV Prostate Cancer
NCT04801381Not Applicable
WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3